Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hemogenyx Pharmaceuticals Plc (GB:HEMO)
:HEMO
Holding GB:HEMO?
Track your performance easily
HEMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range270.00p - 2,853.60p
Previous CloseN/A
Volume114.00
Average Volume (3M)16.89K
Market Cap
£14.07M
Enterprise Value17.17M
Total Cash (Recent Filing)$87.22K
Total Debt (Recent Filing)$263.35K
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.72
Shares Outstanding3,604,539
10 Day Avg. Volume6,641
30 Day Avg. Volume16,890
Standard Deviation0.92
R-Squared0.02
Alpha0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-7.82
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HemoGenyx Pharmaceuticals Plc News
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Boosts Clinical Trials with £340,000 Fundraising
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Updates Company Secretary and Office LocationPremiumCompany Announcements
Hemogenyx Pharmaceuticals Announces Key Corporate Changes
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Initiates Phase I Trial for AML Treatment
PremiumCompany Announcements
Hemogenyx Partners with Kure.ai for Ultrafast CAR-T Manufacturing
PremiumCompany Announcements
HemoGenyx Pharmaceuticals Clears Key Resolutions at MeetingPremiumCompany Announcements
HemoGenyx Advances Clinical Trial for AML TreatmentHEMO FAQ
What was Hemogenyx Pharmaceuticals Plc’s price range in the past 12 months?
Hemogenyx Pharmaceuticals Plc lowest share price was 270.00p and its highest was 2853.60p in the past 12 months.
What is Hemogenyx Pharmaceuticals Plc’s market cap?
Hemogenyx Pharmaceuticals Plc’s market cap is £14.07M.
When is Hemogenyx Pharmaceuticals Plc’s upcoming earnings report date?
Hemogenyx Pharmaceuticals Plc’s upcoming earnings report date is Apr 25, 2025 which is in 97 days.
How were Hemogenyx Pharmaceuticals Plc’s earnings last quarter?
Hemogenyx Pharmaceuticals Plc released its earnings results on Sep 27, 2024. The company reported -0.916p earnings per share for the quarter, missing the consensus estimate of N/A by -0.916p.
Is Hemogenyx Pharmaceuticals Plc overvalued?
According to Wall Street analysts Hemogenyx Pharmaceuticals Plc’s price is currently Overvalued.
Does Hemogenyx Pharmaceuticals Plc pay dividends?
Hemogenyx Pharmaceuticals Plc does not currently pay dividends.
What is Hemogenyx Pharmaceuticals Plc’s EPS estimate?
Hemogenyx Pharmaceuticals Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemogenyx Pharmaceuticals Plc have?
Hemogenyx Pharmaceuticals Plc has 3,604,539 shares outstanding.
What happened to Hemogenyx Pharmaceuticals Plc’s price movement after its last earnings report?
Hemogenyx Pharmaceuticals Plc reported an EPS of -0.916p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.442%.
Which hedge fund is a major shareholder of Hemogenyx Pharmaceuticals Plc?
Currently, no hedge funds are holding shares in GB:HEMO
---
Company Description
Hemogenyx Pharmaceuticals Plc
Hemogenyx Pharmaceuticals PLC and its subsidiary is a preclinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.
---
Technical Analysis
Scancell Holdings
―
Ovoca Gold
―
ValiRx plc
―
Sareum Holdings
―
Genflow Biosciences Plc
―
---